ALPS Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-46,259
| Closed | -$1.85M | – | 1024 |
|
|
2023
Q1 | $1.85M | Sell |
46,259
-1,265
| -3% | -$50.7K | 0.02% | 303 |
|
|
2022
Q4 | $2.2M | Buy |
+47,524
| New | +$2.2M | 0.02% | 283 |
|
|
2017
Q4 | – | Sell |
-41,814
| Closed | -$2.23M | – | 876 |
|
|
2017
Q3 | $2.23M | Buy |
41,814
+3,649
| +10% | +$194K | 0.02% | 180 |
|
|
2017
Q2 | $2.37M | Buy |
38,165
+2,267
| +6% | +$141K | 0.02% | 173 |
|
|
2017
Q1 | $2.43M | Sell |
35,898
-3,366
| -9% | -$228K | 0.02% | 165 |
|
|
2016
Q4 | $2.76M | Sell |
39,264
-11,010
| -22% | -$774K | 0.02% | 161 |
|
|
2016
Q3 | $3.57M | Sell |
50,274
-4,542
| -8% | -$322K | 0.03% | 158 |
|
|
2016
Q2 | $2.68M | Buy |
54,816
+11,142
| +26% | +$545K | 0.02% | 156 |
|
|
2016
Q1 | $2.77M | Sell |
43,674
-7,485
| -15% | -$474K | 0.03% | 138 |
|
|
2015
Q4 | $5.74M | Sell |
51,159
-8,479
| -14% | -$951K | 0.06% | 116 |
|
|
2015
Q3 | $57.4K | Buy |
59,638
+24,008
| +67% | +$23.1K | 0.06% | 105 |
|
|
2015
Q2 | $3.65M | Buy |
35,630
+18,326
| +106% | +$1.88M | 0.03% | 134 |
|
|
2015
Q1 | $1.07M | Buy |
+17,304
| New | +$1.07M | 0.01% | 183 |
|